MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ACH made $2,762,032K in revenue. -$1,100,642K in net income. Net profit margin of -39.85%.

Income Overview

Revenue
$2,762,032K
Net Income
-$1,100,642K
Net Profit Margin
-39.85%
EPS
-$14.31
Unit: Thousand (K) dollars
Revenue Breakdown
    • Diabetes Product
    • Sleep Therapy Product
    • Home Respiratory Therapy Product
    • Others
Revenue Breakdown
    • Commercial Payors
    • Medicare
    • Medicaid

Income Statement
2025-12-31
Net revenue
2,762,032
Cost of net revenue
1,472,733
Selling, general and administrative expenses
1,067,560
Transaction breakage fee
80,000
Acquisition-related charges and intangible amortization
95,832
Exit and realignment charges, net
18,447
Total operating costs and expenses
2,734,572
Operating income (loss)
27,460
Interest expense, net
107,183
Transaction financing fees, net
18,288
Other expense, net
-3,942
(loss) income from continuing operations before income taxes
-101,953
Income tax provision
729
(loss) income from continuing operations, net of tax
-102,682
Net revenue
7,909,655
Cost of goods sold
7,125,144
Gross profit
784,511
Distribution, selling, and administrative expenses
782,789
Acquisition-related charges and intangible amortization
12,549
Exit and realignment charges, net
72,379
Goodwill impairment charge
106,389
Loss on classification to held for sale
798,934
Other operating expense, net
-10,932
Operating (loss) income
-999,461
Interest expense, net
-36,001
Other expense
1,405
Loss from discontinued operations before income taxes
-1,036,867
Income tax benefit for discontinued operations
-38,907
Loss from discontinued operations, net of tax
-997,960
Net loss
-1,100,642
Basic EPS
-14.31
Diluted EPS
-14.31
Basic Average Shares
76,897,000
Diluted Average Shares
76,897,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$1,100,642K Diabetes Product$783,370K Sleep Therapy Product$740,052K Home RespiratoryTherapy Product$433,050K Product And ServiceOther$288,192K Ostomy$212,838K Wound Care$188,508K Urology$116,022K Loss fromdiscontinued operations, net...-$997,960K (loss) income fromcontinuing operations, net...-$102,682K Income tax benefit fordiscontinued operations-$38,907K Net revenue$2,762,032K Loss fromdiscontinued operations...-$1,036,867K (loss) income fromcontinuing operations...-$101,953K Income tax provision$729K Operating income (loss)$27,460K Net revenue$7,909,655K Total operating costsand expenses$2,734,572K Operating (loss) income-$999,461K Interest expense, net-$36,001K Other expense$1,405K Interest expense, net$107,183K Gross profit$784,511K Transaction financing fees,net$18,288K Other expense, net-$3,942K Cost of goods sold$7,125,144K Cost of net revenue$1,472,733K Selling, general andadministrative expenses$1,067,560K Acquisition-related charges andintangible amortization$95,832K Transaction breakage fee$80,000K Exit and realignmentcharges, net$18,447K Loss onclassification to held for sale$798,934K Distribution, selling, andadministrative expenses$782,789K Goodwill impairmentcharge$106,389K Exit and realignmentcharges, net$72,379K Acquisition-related charges andintangible amortization$12,549K Other operatingexpense, net-$10,932K

ACCENDRA HEALTH INC VA (ACH)

ACCENDRA HEALTH INC VA (ACH)